ProCE Banner Activity

Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Argentina

Podcast Episodes
Listen to José Ignacio Nolazco, MD, and Alejandro Nolazco, MD, discuss in Spanish the latest clinical data on immune checkpoint inhibitors for advanced urothelial cancer from an Argentinian perspective.

Released: February 22, 2021

Expiration: February 21, 2022

Share

Faculty

Alejandro Nolazco

Alejandro Nolazco, MD

Associate Professor
Department of Urology
Universidad Austral and Universidad Católica Argentina
Buenos Aires, Argentina

Supporters

Supported by an educational grant from

Pfizer and EMD Serono

Faculty Disclosure

Primary Author

Alejandro Nolazco, MD

Associate Professor
Department of Urology
Universidad Austral and Universidad Católica Argentina
Buenos Aires, Argentina